Completed OBSERVATIONAL NCT01487291

Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients

Sponsor: Rio de Janeiro State Research Supporting Foundation (FAPERJ)

Conditions Insulin Resistance Psychosis Thrombophilia

Updated 6 times since 2017 Last updated: Dec 15, 2014 Started: Jan 31, 2013 Primary completion: May 31, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01487291, this observational or N/A phase trial focuses on Insulin Resistance and Psychosis and remains completed. Sponsored by Rio de Janeiro State Research Supporting Foundation (FAPERJ), it has been updated 6 times since 2013, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Universidade Federal do Rio de Janeiro

Data source: Universidade Federal do Rio de Janeiro

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rio de Janeiro, Brazil